$TNDM News

William Blair Initiates Coverage On Tandem Diabetes Care with Outperform Rating

TNDM Q2 Loss Narrower Than Expected, Revenues Miss, Stock Up

Why Tandem Diabetes (TNDM) Stock Is Trading Up Today

TNDM Q2 Deep Dive: Pharmacy Channel Gains and Pipeline Execution Amid Margin Recovery

Why Tandem Diabetes Care (TNDM) Is Up 14.8% After Record Q2 Sales And PayGo Momentum

Tandem Diabetes Care (TNDM) Could Be 23% Below Fair Value After Q2 Results

Tandem Diabetes Care's Underlying Q2 Trends Better Than Headline Suggests, RBC Says

Tandem Diabetes Care Q2 Earnings Call Highlights

Citigroup Maintains Neutral on Tandem Diabetes Care, Raises Price Target to $21

RBC Capital Maintains Outperform on Tandem Diabetes Care, Lowers Price Target to $26

Tandem Diabetes Care, Inc. 2026 Q2 - Results - Earnings Call Presentation

Tandem Diabetes Care, Inc. Q2 2026 Earnings Call Summary

Tandem Diabetes Care, Inc. (TNDM) Q2 2026 Earnings Call Transcript

Tandem Diabetes Care (TNDM) Reports Q2 Earnings: What Key Metrics Have to Say

Tandem Diabetes’s (NASDAQ:TNDM) Q2 CY2026 Earnings Results: Revenue In Line With Expectations

Tandem Diabetes Care Announces Second Quarter 2026 Financial Results

Tandem Diabetes Care Q2 EPS $(0.31) Beats $(0.32) Estimate, Sales $254.560M Miss $254.978M Estimate

Tandem Diabetes Care Affirms FY2026 Sales Guidance of $1.065B-$1.085B vs $1.074B Est

Tandem Diabetes Care (TNDM) Slid as Lower Beta Profile Lags in Risk On Market

Tandem Diabetes Care Announces Upcoming Conference Presentation